Literature DB >> 1233263

Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration.

A Berlin, H Dahlström.   

Abstract

Eight healthy volunteers were given single i.v. and oral doses of clonazepam (2 mg). The disposition curves after i.v. administration showed a biexponential decline and the data were applied to a two-compartment open model. The volume of distribution ((Vd)beta) ranged between 1.5 and 4.4 l/kg and the plasma half-life (t1/2) between 19 and 60 hours. Absorption after oral administration was fast, with peak plasma concentrations within 4 hours in all subjects. Five of the subjects received repeated oral doses of clonazepam 0.5 mg bid for 15 days. The plasma level during steady state (estimated as Cmin within the dose interval) could be predicted from the constants A, B, alpha and beta obtained in the single dose study with a coefficient of variation of 6%. The plasma half-lives after cessation of the subchronic dosing were of the same magnitude as after single doses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233263     DOI: 10.1007/bf00614012

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Streptomycin in the blood; chemical determinations after single and repeated intramuscular injections.

Authors:  G E BOXER; V C JELINEK
Journal:  J Pharmacol Exp Ther       Date:  1948-03       Impact factor: 4.030

2.  Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.

Authors:  S A Kaplan; K Alexander; M L Jack; C V Puglisi; J A De Silva; T L Lee; R E Weinfeld
Journal:  J Pharm Sci       Date:  1974-04       Impact factor: 3.534

3.  [Studies on the disposition of the anticonvulsant clonazepam in the organisms of rat, dog, and man].

Authors:  E Eschenhof
Journal:  Arzneimittelforschung       Date:  1973-03

4.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

5.  Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data.

Authors:  A Berlin; B Siwers; S Agurell; A Hiort; F Sjöqvist; S Ström
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

6.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

  6 in total
  14 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

Review 2.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  Influence of phenobarbital on the disposition of clonazepam and antipyrine in the dog.

Authors:  I Bekersky; A C Maggio; V Mattaliano; H G Boxenbaum; D E Maynard; P D Cohn; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Clonazepam in breast milk.

Authors:  P Söderman; I Matheson
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

5.  Comparative pharmacokinetics of benzodiazepines in dog and man.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

6.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

7.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-11       Impact factor: 9.546

10.  Respiratory arrest and oversedation in an adolescent given intramuscular clonazepam for rapid tranquillization.

Authors:  Jonathan Channing; Simon Hill; Marion Wetherill; Oliver White
Journal:  Ther Adv Psychopharmacol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.